• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估多糖伤寒 Vi 抗体反应作为血液恶性肿瘤体液免疫缺陷的预测指标。

Evaluation of Polysaccharide Typhim Vi Antibody Response as a predictor of Humoral Immunodeficiency in Haematological Malignancies.

机构信息

Department of Immunology, IML and IdSSC, Hospital Clínico San Carlos, Madrid, Spain; Department of Immunology, Ophthalmology and ENT, School of Medicine, Complutense University School of Medicine, Madrid, Spain; Immunodeficiency Interdepartmental Group, (GIID), Madrid, Spain.

Department of Haematology, Hospital Clínico San Carlos, Madrid, Spain.

出版信息

Clin Immunol. 2020 Jan;210:108307. doi: 10.1016/j.clim.2019.108307. Epub 2019 Nov 21.

DOI:10.1016/j.clim.2019.108307
PMID:31760095
Abstract

An increasing healthcare challenge in the management of haematological malignancy (HM) is secondary immunodeficiency. From January 2019, the EMA included the evaluation of specific antibody (Ab) responses to better select patients for immunoglobulin replacement therapy (IgRT). We evaluated Ab responses to pneumococcal and Salmonella typhi pure polysaccharide immunization in a cohort of 42 HM patients and 24 healthy-controls. Pre-post specific Ab concentrations were measured by ELISA at 4 weeks. Globally, significantly lower Typhim Vi (TV) seroprevalence (9%) compared to 23-valent pneumococcal polysaccharide vaccine (PPV) (76%) (p <0.001) was observed. TV non responders (88%) were higher than PPV non responders (62%) (p <0.0001) and correlated better to infectious history. By ROC analysis, pre-post 5-fold TV increase was the best cut-off to discriminate HM with recurrent infections and controls (sensitivity 91%, specificity 100%). Despite the small sample cohort, our results suggest that specific anti-S typhi Ab response is a useful complementary assay in the diagnosis and management decision of SID to HM.

摘要

在血液恶性肿瘤(HM)的管理中,继发性免疫缺陷是一个日益严峻的医疗挑战。自 2019 年 1 月起,EMA 已将特定抗体(Ab)反应的评估纳入其中,以更好地选择接受免疫球蛋白替代治疗(IgRT)的患者。我们评估了 42 例 HM 患者和 24 例健康对照者对肺炎球菌和伤寒沙门氏菌纯多糖免疫的 Ab 反应。在 4 周时通过 ELISA 测量 Ab 浓度的前后变化。总的来说,与 23 价肺炎球菌多糖疫苗(PPV)(76%)相比,Typhim Vi(TV)血清阳性率(9%)明显较低(p<0.001)。TV 无反应者(88%)高于 PPV 无反应者(62%)(p<0.0001),且与感染史相关性更好。通过 ROC 分析,前后 5 倍 TV 增加是区分 HM 患者复发性感染和对照组的最佳截断值(敏感性 91%,特异性 100%)。尽管样本量较小,但我们的结果表明,针对伤寒沙门氏菌的特异性抗 Ab 反应是诊断和管理 HM 患者 SID 的一种有用的补充检测方法。

相似文献

1
Evaluation of Polysaccharide Typhim Vi Antibody Response as a predictor of Humoral Immunodeficiency in Haematological Malignancies.评估多糖伤寒 Vi 抗体反应作为血液恶性肿瘤体液免疫缺陷的预测指标。
Clin Immunol. 2020 Jan;210:108307. doi: 10.1016/j.clim.2019.108307. Epub 2019 Nov 21.
2
Measurement of Typhim Vi IgG as a Diagnostic Tool to Determine Anti-polysaccharide Antibody Production Deficiency in Children.采用 Typhim Vi IgG 检测作为诊断工具,以确定儿童抗多糖抗体产生缺陷。
Front Immunol. 2019 Apr 2;10:654. doi: 10.3389/fimmu.2019.00654. eCollection 2019.
3
Measurement of Typhi Vi antibodies can be used to assess adaptive immunity in patients with immunodeficiency.检测伤寒 Vi 抗体可用于评估免疫缺陷患者的适应性免疫。
Clin Exp Immunol. 2018 Jun;192(3):292-301. doi: 10.1111/cei.13105. Epub 2018 Apr 1.
4
The Use of Salmonella Typhim Vaccine to Diagnose Antibody Deficiency.使用伤寒沙门氏菌疫苗诊断抗体缺陷。
J Clin Immunol. 2017 Jul;37(5):427-433. doi: 10.1007/s10875-017-0406-6. Epub 2017 Jun 7.
5
Multicenter study for the evaluation of the antibody response against salmonella typhi Vi vaccination (EMPATHY) for the diagnosis of Anti-polysaccharide antibody production deficiency in patients with primary immunodeficiency.多中心研究评估伤寒Vi疫苗接种的抗体反应(EMPATHY)用于诊断原发性免疫缺陷患者抗多糖抗体产生缺陷
Clin Immunol. 2016 Aug;169:80-84. doi: 10.1016/j.clim.2016.05.006. Epub 2016 May 25.
6
Measurement and interpretation of Salmonella typhi Vi IgG antibodies for the assessment of adaptive immunity.用于评估适应性免疫的伤寒沙门氏菌Vi IgG抗体的检测与解读。
J Immunol Methods. 2018 Aug;459:1-10. doi: 10.1016/j.jim.2018.05.013. Epub 2018 May 22.
7
Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.对口服伤寒沙门氏菌Ty21a疫苗和肠外Vi荚膜多糖伤寒疫苗同时接种的特异性和交叉反应性免疫应答。
Vaccine. 2015 Jan 9;33(3):451-8. doi: 10.1016/j.vaccine.2014.11.030. Epub 2014 Nov 26.
8
Defining Polysaccharide Antibody Deficiency: Measurement of Anti-Pneumococcal Antibodies and Anti-Salmonella typhi Antibodies in a Cohort of Patients with Recurrent Infections.定义多糖抗体缺陷症:在复发性感染患者队列中测量抗肺炎球菌抗体和抗伤寒沙门氏菌抗体。
J Clin Immunol. 2020 Jan;40(1):105-113. doi: 10.1007/s10875-019-00691-8. Epub 2019 Nov 8.
9
Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi).用伤寒多糖疫苗(Typhim-Vi)免疫HIV感染者后抗体反应受损。
Vaccine. 1999 Aug 6;17(23-24):2941-5. doi: 10.1016/s0264-410x(99)00167-x.
10
A phase 1 randomized safety, reactogenicity, and immunogenicity study of Typhax: A novel protein capsular matrix vaccine candidate for the prevention of typhoid fever.一项评估 Typhax 的安全性、反应原性和免疫原性的 1 期随机临床试验:一种新型蛋白荚膜基质疫苗候选物,用于预防伤寒。
PLoS Negl Trop Dis. 2020 Jan 6;14(1):e0007912. doi: 10.1371/journal.pntd.0007912. eCollection 2020 Jan.

引用本文的文献

1
Dissecting Secondary Immunodeficiency: Identification of Primary Immunodeficiency within B-Cell Lymphoproliferative Disorders.解析继发性免疫缺陷:B 细胞淋巴增殖性疾病中的原发性免疫缺陷的鉴定。
J Clin Immunol. 2024 Oct 23;45(1):32. doi: 10.1007/s10875-024-01818-2.
2
Access and use of immunoglobulins in supportive cancer care: A thematic analysis of a systematic review data set.支持性癌症护理中免疫球蛋白的获取与使用:对系统评价数据集的主题分析
J Med Access. 2024 Mar 28;8:27550834241236596. doi: 10.1177/27550834241236596. eCollection 2024 Jan-Dec.
3
Access and use of immunoglobulins in secondary supportive cancer care: A systematic literature review.
继发性支持性癌症护理中免疫球蛋白的获取与使用:一项系统文献综述
J Med Access. 2023 Oct 14;7:27550834231197315. doi: 10.1177/27550834231197315. eCollection 2023 Jan-Dec.
4
Combined Immune Defect in B-Cell Lymphoproliferative Disorders Is Associated with Severe Infection and Cancer Progression.B细胞淋巴增殖性疾病中的联合免疫缺陷与严重感染和癌症进展相关。
Biomedicines. 2022 Aug 19;10(8):2020. doi: 10.3390/biomedicines10082020.
5
Ultrasonic-Assisted Extraction of Glucofructan: Optimization, Structure, and Immunoregulatory Activity.超声辅助提取低聚果糖:优化、结构与免疫调节活性。
Nutrients. 2022 Feb 22;14(5):927. doi: 10.3390/nu14050927.
6
B-cell haematological malignancies and SARS-CoV-2 infection: Could immunological interventions influence the outcome?B细胞血液系统恶性肿瘤与SARS-CoV-2感染:免疫干预能否影响预后?
EJHaem. 2021 Jun 19;2(3):503-507. doi: 10.1002/jha2.249. eCollection 2021 Aug.
7
Variable immunodeficiency score upfront analytical link (VISUAL), a proposal for combined prognostic score at diagnosis of common variable immunodeficiency.初步分析关联的可变免疫缺陷评分(VISUAL),一种用于普通可变免疫缺陷症诊断时联合预后评分的建议。
Sci Rep. 2021 Jun 9;11(1):12211. doi: 10.1038/s41598-021-91791-2.
8
Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?血清游离免疫球蛋白轻链:常见可变免疫缺陷的共同特征?
Front Immunol. 2020 Aug 11;11:2004. doi: 10.3389/fimmu.2020.02004. eCollection 2020.
9
IGA Antibody Induced by Immunization With Pneumococcal Polysaccharides Is a Prognostic Tool in Common Variable Immune Deficiencies.免疫接种肺炎球菌多糖诱导的 IGA 抗体是普通可变免疫缺陷的预后工具。
Front Immunol. 2020 Jun 24;11:1283. doi: 10.3389/fimmu.2020.01283. eCollection 2020.
10
Typhim vi immunization assists to discriminate primary antibody responses in hematological malignancies.伤寒Vi免疫有助于区分血液系统恶性肿瘤中的原发性抗体反应。
MethodsX. 2020 May 29;7:100936. doi: 10.1016/j.mex.2020.100936. eCollection 2020.